A detailed history of Man Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Man Group PLC holds 157,598 shares of HRMY stock, worth $5.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
157,598
Previous 144,559 9.02%
Holding current value
$5.33 Million
Previous $4.85 Million 2.06%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $375,653 - $430,417
13,039 Added 9.02%
157,598 $4.75 Million
Q1 2024

May 15, 2024

BUY
$29.93 - $35.06 $156,084 - $182,837
5,215 Added 3.74%
144,559 $4.85 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $773,606 - $1.36 Million
40,292 Added 40.68%
139,344 $4.5 Million
Q3 2023

Nov 14, 2023

SELL
$31.89 - $39.03 $7.01 Million - $8.58 Million
-219,847 Reduced 68.94%
99,052 $3.25 Million
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $5 Million - $6.13 Million
163,797 Added 105.61%
318,899 $11.2 Million
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $2.52 Million - $4.42 Million
-81,900 Reduced 34.56%
155,102 $5.06 Million
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $1.48 Million - $1.99 Million
-32,622 Reduced 12.1%
237,002 $13.1 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.67 Million - $2.2 Million
39,635 Added 17.23%
269,624 $11.9 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $52.15 $3.76 Million - $5.84 Million
112,019 Added 94.96%
229,989 $11.2 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $3.36 Million - $5.18 Million
101,329 Added 608.91%
117,970 $5.74 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $354,910 - $457,147
10,411 Added 167.11%
16,641 $710,000
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $159,986 - $240,540
6,230 New
6,230 $239,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.